1.
Piasecki A, Sitnik M, Olszewski J, Bara M, Herjan K, Armański P. The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health. Prosp. Pharm. Sc. [Internet]. 2024 Feb. 13 [cited 2024 May 18];22(1):11-5. Available from: https://prospects.wum.edu.pl/index.php/pps/article/view/181